Anti Retroviral Market Overview:
A retrovirus is a group of viruses related to the Retroviridae family that perform their genetic blueprint in the form of ribonucleic acid RNA. Anti-retroviral drugs prevent these viruses from multiplying rather than killing them. Anti-retroviral drugs are medicines for the treatment of retroviral infection, mainly HIV. The global market for antiretroviral drugs is anticipated to record a CAGR of 4.0% during the forecast period 2018-2025.
Request a Sample Copy of this Report @ https://www.planetmarketreports.com/report-sample/anti-retroviral-drugs-market
Increasing Prevalence of HIV:
According to the United States Health & Human Services Department, around 36.7 million individuals globally were living with HIV / AIDS, of which 2.1 million were children. An estimated 1.8 million people worldwide were newly infected with HIV in 2016. Anti-retrovirals ARVs are the foundation of HIV / AIDS management, as there is currently no cure or vaccine available for HIV. In people with a non-resistant HIV strain, antiretroviral treatment can suppress HIV replication in about 80% of cases. This huge patient pool shows that in the forecast period, the market for anti-retroviral drugs will grow at a rapid CAGR. Increasing investment in antiviral R&D, increasing prevalence rate of retroviral diseases, and high unmet people’s needs are some of the other factors contributing to market growth.
Side Effects of Drugs:
There have been noted side effects of antiretroviral drugs in some patients, such as loss of appetite, lipodystrophy, diarrhea, fatigue, and high triglyceride & cholesterol levels, and there has been a pressing concern that needs to be addressed. In addition, the lack of effective drugs and increasing drug candidates’ failure rate also restrict the growth of the anti-retroviral drugs market.
Get Detailed Information about this Research Report @ https://www.planetmarketreports.com/reports/anti-retroviral-drugs-market
North America is dominating the market growth
The report on antiretroviral drugs is segmented by drug type and geography. It is segmented by geography into North America, Europe, Asia-Pacific, Middle East & Africa, and South America. Due to better healthcare infrastructure and R&D capabilities, North America dominates the market.
Major Players: Roche, Gilead, GlaxoSmithKline, Bristol-Myers-Squibb, Abbott, AstraZeneca, Merck, Johnson and Johnson, Boehringer Ingelheim, and Novartis AG, among others.
Contact Info:
Name: Jennifer Daniel
Email-Id: sales@planetmarketreports.com
US: +1-716-2260907
UK: +447441952057
Organization: Planet Market Reports
As the world economy struggles to recover from the pandemic, the vaccination drive spells hope…
UAE based companies and agencies have no option but to penetrate new markets more effectively…
Latest Report on Global Sodium Chloride Injection including Market Landscape, and Market size, Revenues by…
Latest Report on Global Varicose Vein Treatment Devices including Market Landscape, and Market size, Revenues…
Latest Report on Global Colorectal Cancer Therapeutics Market including Market Landscape, and Market size, Revenues by players,…
To celebrate World Poetry Day, International Schools Partnership (ISP) has launched a student Poetry Contest…